I believe many doctors are now looking at a top down approach. My son went from the very 'bottom' to the 'top' in one move.
When he was diagnosed, he was with a ped GI. His treatment was six weeks of exclusive enteral nutrition (formula only, no food) to induce remission. It did induce clinical remission (no outward symptoms) and did reduce inflammation. He then continued on supplemental EN (1/2 dose, regular diet) for the next year and a half. During follow-ups, ped GI did mention that metho or other might be needed as MREs continued to show inflammation (but still no outward symptoms). but, as all else seemed fine, GI was content to leave supplemental EN as the only treatment. As my son would be transferred to an adult GI in the coming months, I believe that may have played into his decision to leave treatment untouched and let his new (adult) GI make the decision for future, continuing treatment.
Upon transfer to adult GI, this GI was adamant that the continuing inflammation would eventually bring about serious issues, possibly surgery and strongly recommended remicade.
I did question LDN (GI didn't feel there was enough research) and other immunosuppressants such as 6MP, aza or metho. GI explained that remicade (or humira) were the best out there, so why not use them now? Rather than use something that would possibly not be as successful and then be in a position where the 'best' would no longer be able to treat the complications (ie scar tissue requiring surgery). My son did not want to risk surgery and chose to move straight to remicade.
Wasn't an easy decision for me when he felt and looked good but MREs and scope told a different story.
My other 'justifications' were that:
1. it seems many people eventually move to biologics anyway, so I thought it made sense to go with the 'best' and try to dodge any permanent damage
2. seems cancer risk is greater when an immunosuppressant and then biologic are used, again thought if I could skip the immunosuppressant, would minimize risk (more recently, have read that cancer risk seems to be more linked to immunosuppressors rather than biologic - but not sure how accurate this is)
3. also have read that remicade (perhaps, all biologics) have a greater success rate if used as the first drug treatment and if used within two years of diagnosis - both applied to my son.
But, having said all this, there is no right or wrong way to treat. Although my son has had no problems with remicade thus far, I still would have preferred to have tried LDN first. But, without a crystal ball, there's no way of knowing how things would have turned out. All you can do is make a decision based on the information you have and what you are comfortable with. :ghug: